AstraZeneca Upgrades U.S. Listing Amid Growth Focus on Pharma’s Largest Market | MarketWire
AstraZeneca's strategic U.S. listing upgrade signals a shift toward growth in the world’s largest pharma market, sparking investor interest and trading gains.